What does BayCurrent do?
BayCurrent is a consulting firm built in Japan, tied to no foreign parent and no domestic corporate group. It sells project work to the country's biggest companies: corporate strategy, digital transformation (DX), generative-AI adoption, and the IT implementation that follows. Clients pay for consultant time, project by project; there is no subscription layer. The firm keeps its roughly 5,600 consultants in one pool rather than in fixed industry teams, assembling each project team to fit the theme and reassigning people as demand shifts.
In FY02/26 (the year ended February 2026), revenue grew 27.8% to ¥148.3bn and operating profit grew 19.5% to ¥50.9bn — a 34.3% margin. Return on capital employed was 46%, return on equity 35.8%, and the balance sheet held ¥65.7bn of net cash. Guidance for FY02/27 calls for revenue of ¥190bn, up 28%, and operating profit of ¥64.8bn, up 27%.
The investment question: can a business that bills human hours keep growing at 25%+ in the age of generative AI — and can it hire 25% more consultants a year without diluting quality? This report walks through the price history, the three live debates, the disclosures that could change how the market values the business, and a set of valuation scenarios.
Why has the stock moved over the past two years?
The chart below splits the past 24 months into four regimes. From a June 2024 low of ¥3,059 through a ¥9,075 peak, down 57% in under five months, then a recovery to ¥5,857 — we trace what drove each phase.
01 · THE CLIMB From a low of ¥3,059 in June 2024 the stock rose for sixteen months, because the business kept growing underneath it. FY02/25 (the year ended February 2025) closed with revenue up 23.6% and operating profit up 24.5%. The April 2025 results then paired FY02/26 guidance of ¥143bn revenue with a dividend raised 61% to ¥100. Each quarter through 2025 confirmed the pattern: consultants, projects, and revenue per consultant all rising at once. The close peaked at ¥9,075 on October 6, 2025 — ~26x the operating profit the company was then guiding toward.
02 · THE SLIDE Between October 2025 and February 24, 2026 the stock fell 57% to ¥3,861. The business did not slow — the January quarterly release showed revenue still growing 27% — but two doubts grew. Half-year results had shown consultant count nearly flat since February (4,784 to 4,842) — the visible cost of a one-time reallocation into industry and theme teams. Investors read the stall as the growth model failing. At the same time a second question — could generative AI shrink demand for billed hours? — hit consulting firms hardest. The multiple fell from ~26x to ~10x forward operating profit.
03 · THE BUYBACK RESPONSE On March 18, 2026 the board responded to the share price directly: a buyback of up to 6.6 million shares or ¥30bn — 4.3% of shares outstanding excluding treasury, ten times the prior year's program. The disclosure cited the gap between the share price and fundamentals, and every repurchased share is to be cancelled on August 19, 2026. Full-year results on April 14 then showed revenue of ¥148.3bn, ¥5.3bn above the initial plan, and guided FY02/27 at ¥190bn revenue (up 28%) and ¥64.8bn operating profit (up 27%). The stock recovered to the mid-¥5,000s.
04 · CURRENT At ¥5,857 (June 4, 2026) the stock trades at 12.7x forward EV/EBIT on the FY02/27 operating-profit guidance, with the buyback running through July 31. The next four quarters test three planned numbers, laid out in the company's results FAQ. Consultant count is planned to grow about 25% to roughly 7,000 (including about 710 new graduates), with projects up about 25% and revenue per consultant up about 5%. Utilization is managed inside an 80–90% band; the EBITDA margin is promised inside 30–40%. Q1 results, due around mid-July 2026, are the first checkpoint.
Three questions the market is debating
Three open questions surface in the company's recent results, its investor FAQ, and the price action. For each, we present the bull and bear arguments and the disclosures that would settle the debate.
What could change over the next twelve months?
Three actions management could take, drawn from the company's own disclosures. Each could shift how the market values the business without requiring higher earnings.
What has to be true for the stock to work from here?
The scenarios below are JII estimates, not company guidance. They start from the June 4 closing price of ¥5,857, FY02/27 company operating-profit guidance of ¥64.8bn, and enterprise value (market capitalization minus net cash) of ¥824bn. Ranges combine consultant-count, billing-rate, and margin outcomes.
- Revenue per consultant flat or below plan
- Projects grow below 20%
- Utilization at the bottom of the band
- Operating profit lands near ¥60bn
- Consultants reach ~7,000 (+25%)
- Revenue per consultant up ~5%
- Buyback completes; all shares cancelled
- EBITDA margin holds near 35%
- Revenue per consultant beats +5% plan
- FY02/28 guidance keeps ~25%+ growth
- Second ¥20bn+ buyback within 12 months
- EBITDA margin at 35% or above
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator under Japan's Financial Instruments and Exchange Act. JII does not have an investment advisory registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR diagnostic, translation, or interpretation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。